BrainStorm Cell Therapeutics , a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the European Commission has granted Orphan Drug Designation for NurOwn, the Company's stem cell therapy consisting of autologous bone marrow-derived mesenchymal stromal cells secreting neurotrophic factors, for the ... (more)
http://www.biospace.com/news_story.aspx?StoryID=304056&full=1
http://www.biospace.com/news_story.aspx?StoryID=304056&full=1
No comments:
Post a Comment